# Aloe Therapeutics Inc. — Form D

Aloe Therapeutics Inc. of DARNESTOWN, MD, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-18. The offering totals $100K, of which $100K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-03-18
- Form: D
- Accession: 0002009614-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $100K
- Amount sold: $100K
- Investors: 1
- Date of first sale: 2024-03-04
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-507842

## Issuer

- Name: Aloe Therapeutics Inc.
- CIK: 0002009614
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 14517 BROOKMEAD DRIVE, DARNESTOWN, MD, 20874
- Phone: 412-425-4138

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Martha Sklavos | Director | Darnestown, MD |
| Martha Sklavos | Executive Officer | Darnestown, MD |

## More

- [CIK 2009614 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2009614&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002009614-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.